BUSINESS BRIEF
It is an established pharmaceutical company specializing in generic drugs, over-the-counter medicines, prescription formulations, cosmeceuticals, and nutraceuticals. The company operates in multiple therapeutic areas, including cardiovascular, neurology, anti-infective, analgesic, anti-ulcerants, ortho, derma, diabetic care, and nutraceuticals.
- With a strong presence across 180 districts in India, the company has achieved consistent growth without external funding.
- The company is in growth-stage that operate in market with high barriers to entry. The businesses has strong fundamentals, reasonable profit margins and significant growth potential.
- It is into E-Commerce & Retailing business also
Manufacturing & Compliance:
- In-house nutritional supplements manufacturing facility with FSSA & USFDA registrations
- Outsourced production for all other drug formulations
- Fully compliant with WHO-GMP, FDA
- Patents under application process, with multiple registered brands
Highlights:
- 400+ products in the market
- Domestic (90%) & Export (10%) market share
- Registered and marketed in international markets
- Competitive edge through strong brand presence and differentiation
- The company is now strategically planning for an SME public listing by 2026
Products & Services
- Pharmaceutical products
- Nutraceutical products
- Animal Healthcare products (Specialized focus in poultry)
Proposal
Industry
Pharmaceuticals
Sub Industry
Formulation
Nature of Business
B2B, B2C
Sector
Manufacturing (Own Brand & Contract Manufacturing)
Reason for sell-off
Strategic Realignment or Pursuing New Opportunities
Location
India
Region
Southern
Open For Dilution
100 % (Complete Buyout)
Top Customer
Deal Size
INR 60 - 70 Cr
Justification
na
Business Operation Information
Financial Information |
2024 (in INR Cr) | 2023 (in INR Cr) | 2022 (in INR Cr) |
|---|---|---|---|
Sales |
9.55 | 9.29 | 16.13 |
EBITDA |
|||
PAT |